AVIENT CORP (AVNT)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for AVNT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AVNT | Senior Advisor | 68 | ["Former Vice President, Chief Financial Officer of Stryker Corporation", "Senior Vice President and Chief Financial Officer of Dentsply International", "Extensive experience in the Medtech industry", "Diverse operating experiences in international markets"] | ["M"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ANIK | 67 | [] | [] | 2025 | |
| MDT | Retired Chief Financial Officer | 67 | ["Corporate finance expert", "Retired MedTech executive", "Former CFO of Stryker Corporation", "15 years at Dentsply International in leadership positions", "Multiple financial management and executive roles at Donnelly Corporation", "Director on the Board of Anika Therapeutics, Inc., Avient Corporation, Solenis, and Young Innovations, Inc.", "Previous chairman of the audit committee at Masimo Corporation", "Senior Advisor for Astor Place Holdings", "Consulted with other companies in the MedTech industry", "40 years of business, financial, and executive management experience"] | ["AFC", "M", "Growth", "Operations"] | 2025 |
| SYK | Vice President and Chief Financial Officer | [] | [] | 2014 |
Biography sourced from the proxy statement filing.
Former Vice President, Chief Financial Officer of Stryker Corporation ( Stryker ), one of the world s leading medical technology ( Medtech ) companies. Since 2017, Mr. Jellison has served as Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and consults with other private equity and investment management firms in the Medtech industry. Previously, Mr. Jellison served as Vice President, Chief Financial Officer of Stryker from 2013 to 2016. Prior to joining Stryker, Mr. Jellison served as the Senior Vice President and Chief Financial Officer of Dentsply International ( Dentsply ), the world s largest manufacturer of professional dental products, from 1998 to 2013, except for a roughly two-year period of time between 2002 and 2005 when he was a Senior Vice President with full P&L responsibilities for some of Dentsply s operating divisions located in the U.S., Europe and Asia. Mr. Jellison began his career with the Donnelly Corporation, a publicly traded international automotive parts supplier, where he served in several senior leadership roles, advancing to Vice President of Finance. Qualifications, Attributes, Skills and Experience: We believe that Mr. Jellison brings a unique perspective to the Board, especially with respect to opportunities to further specialize in the healthcare industry. In addition, Mr. Jellison brings substantial financial experience from a large, publicly-traded company to the Board. His experience abroad also provides him with diverse operating experiences in international markets, which provides the Board with a meaningful global business perspective. Mr. Jellison is able to use his experience in serving as an executive at a respected Medtech company to guide our Board in providing strategic insight with respect to market specialization. Director since: 2015 Age: 68 Current Public Company Directorships: Anika Therapeutics, Inc. Medtronic plc Current Non-Public Company Directorships: Solenis Holding Limited Young Innovations, Inc. Former Directorships: PracticeWorks, Inc. Masimo Corporation